CN103185797B

CN103185797B - Reagent device and method for detecting anti-myeloperoxidase antibody

Info

Publication number: CN103185797B
Application number: CN201110453973.7A
Authority: CN
Inventors: 胡德明; 刘清波; 何林; 阳辉
Original assignee: Shenzhen Yhlo Biotech Co Ltd
Current assignee: Shenzhen Yhlo Biotech Co Ltd
Priority date: 2011-12-30
Filing date: 2011-12-30
Publication date: 2015-02-04
Anticipated expiration: 2031-12-30
Also published as: CN103185797A

Abstract

The invention provides a reagent device and a method used for detecting anti-myeloperoxidase antibodies. The reagent device has a long strip shape, and has a base body comprising 8 hole positions and a handle positioned on one end of the base body. From the end proximal to the handle, the 8 hole positions are sequentially a sample hole, an auxiliary agent hole, an enzyme conjugate hole, a substrate hole, a termination liquid hole, a dilution liquid hole, a reaction hole, and a dilution hole. According to the invention, based on a principle of enzyme-linked immunoassay, anti-myeloperoxidase antibody is detected by using the reagent device. The method is an independent single-person analysis and detection method. The device can be used in cooperation with a corresponding specific analysis instrument. During a detection process, detection reagents or samples are injected by using a full-automatic precise dosing device. The device and the method have the advantages of automatic operation, precise dosing, high detection result accuracy, high detection result precision, and wide application prospect.

Description

A kind of reagent device and method thereof detecting antimyeloperoxidase antibody

Technical field

The present patent application relates to a kind of reagent device and the method thereof that detect antimyeloperoxidase antibody, belongs to clinical immunology detection technique field.

Background technology

Vasculitis be one group with the inflammation of blood vessel and the downright bad inflammatory disease for main pathological change, clinical manifestation shows different because the type of involved vessels, size, position and pathological characteristic are different.It often involves the multiple system of whole body (such as skin, kidney, lung, nervous system etc.), causes the dysfunction of multisystem, multi viscera, but also can be confined to a certain internal organs.

Myeloperoxidase (MPO) is the main target antigen of ANCA (ANCA), that neutrophil cell kills the important substance of engulfing microorganism, MPO antibody belongs to the one of ANCA, mainly for neutrophil leucocyte and the granulocytic cytosolic fraction of monokaryon.The crescentic glomerulonephritis of 64% can detect MPO antibody, and microscopic polyangitis patient positive rate is 60%; Allergic granulomatous angiitis patient can detect MPO antibody; Wegener granulomatosis patient positive rate is 24%, all points out MPO antibody relevant with vasculitic mechanism of causing a disease in many bodies with external data.

The common methods of clinical detection antimyeloperoxidase antibody comprises indirect immunofluorescence and ELISA method, and indirect immunofluorescence is a kind of prescreening method, ELISA method difinite quality and immue quantitative detection reagent box, but these methods all also exist weak point.

One, indirect immunofluorescence

The ultimate principle of this method forms antigen antibody complex after being combined with the antigen of specific antibody in microslide, continues and use fluorescence antibody to be combined with antigen antibody complex, form antigen-antibody fluorescent composition.Under fluorescent microscope, the luminous situation according to compound determines detected antibody.The method increases due to the fluorescence antibody be combined on antigen antibody complex, and the fluorescent brightness sent is strong, and thus its susceptibility is strong, but it also has following weak point:

(1) cannot according to the non-specific identification of the size discrimination of molecular weight when analysis result;

(2) operate relative complex, need price fluorescent microscope costly, be difficult to promote at a lot of basic hospital, be also not too applicable to the more laboratory of specimen amount;

(3) background in fluorometric assay is higher, and immunofluorence technic is used for quantitative measurement certain difficulty;

(4) result judges to need experienced professional, and the objectivity of analysis result is not enough;

(5) can only qualitative detection be carried out, can not quantitative measurement be carried out;

(6) because the fluorescence mode that ANCA (ANCA) produces comprises endochylema type (cANCA), core week type (pANCA), two kinds of fluorescence mode can for multiple specific target antigen, so for vasculitic diagnosis, also need after the ANCA Immunofluorescence test positive to use additive method (as enzyme exempts from method) to carry out the further confirmation of antibody.

Two, enzyme linked immunosorbent assay

Enzyme linked immunosorbent assay (ELISA) is widely used in detecting antimyeloperoxidase antibody, but the method also also exists following weak point:

(1) use 12 × 8 types, 6 × 8 types, 8 × 12 types or complete plate 96 hole Special micro porous plate as antigen coated apparatus and reaction vessel, 12 batches, 6 batches, 8 batches can only be divided in use or whole plate once uses, cannot carry out independently, the detection of single part;

(2) reagent type that quantitative measurement is used is more, each detects reagent and all carrys out splendid attire with reagent bottle, and all need to change imbibition nozzle when often using a kind of reagent to be filled into respectively in the micropore of microwell plate, not only reagent bottle kind is many, and the operation of filling reagent is also very loaded down with trivial details;

(3) the corresponding mark to Detection Information is lacked, can only by checking that the product batch number and term of validity information detecting reagent could be understood or know to the mark of kit external packing box, and the information known is not controlled in testing process, there is very large randomness;

(4) detect reagent in testing process, be in open space, easily cause the cross pollution between various reagent and affect the accuracy of testing result;

(5) the many employing manual operationss of testing process, the dosage of reagent or sample is not bery accurate, and operating process is very loaded down with trivial details and complicated, easily bust occurs, and accuracy and the precision of testing result are poor;

(6) in the quantity configuration and use of test item reagent set, item number × 48/96 person-portion is, if need detection 10 projects, then reagent configuration and use number must be 10 × 48/96 person-portions, if only have the project that a sample needs detection 10 different, also need the reagent of configuration 10 × 48/96 person-portion, there is the shortcoming of inadequate economical rationality.

Summary of the invention

Namely patented claim of the present invention is at present for above shortcomings part in the detection of anti-myeloperoxidase (MPO) antibody, provides a kind of reagent device and the detection method thereof that can carry out the detection of separate single person-portion.

Patented claim of the present invention realizes the detection of antimyeloperoxidase antibody based on the principle of enzyme linked immunosorbent detection, be a kind of independently, single part, the disposable method of inspection; Further, the present patent application additionally provides the corresponding reagent device supporting to the method, plurality of reagents required for antimyeloperoxidase antibody enzyme linked immunosorbent detection is contained in one independently, in the reagent device of porous structure, moved abandoned detecting step by substep filling by this reagent device; Further, described reagent device can also carry out corresponding fully-automated synthesis by special immunity analysis instrument.

One of object of the present patent application is to provide a kind of reagent device detecting antimyeloperoxidase antibody, and this object is realized by following technical scheme:

Specifically, the reagent device of the detection antimyeloperoxidase antibody described in the present patent application is strip, comprise the matrix with position, eight holes and the handle being positioned at matrix one end, putting in order of position, eight holes is followed successively by sample aperture near handle end, assistant agent hole, enzyme conjugates hole, substrate hole, stop fluid apertures, dilution fluid apertures, reacting hole and dilution holes, sample to be tested is filled in sample aperture, assistant agent hole adds auxiliary reagent whenever necessary for detection, enzyme conjugates solution is filled in enzyme conjugates hole, substrate fills substrate solution in hole, stop filling stop buffer in fluid apertures, dilution is filled in dilution fluid apertures, reacting hole is flat and has high light penetrability, hole endoperidium has myeloperoxidase antigen, and to annotate liquid sample to be measured and detect reagent and cleansing solution as reaction vessel, absorbance measurement is carried out after reaction terminating, dilution holes is as Sample Dilution container, during for diluted sample.

Further, in described reagent device, assistant agent hole, enzyme conjugates hole, substrate hole, termination fluid apertures and dilution fluid apertures are coated with sealing film, sealing film mainly plays and prevent the effect of overflow in the process of transport and movement, in addition, the effect that preventing dust pollutes and strengthens stability is also played.

Further, described handle is pasted with bar code, this bar code identification has antimyeloperoxidase antibody to detect the relevant information of reagent and analytical equipment.

Further, described information comprises test item code, detects the sequence number of reagent product batch number, the reagent term of validity, quantitative measurement standard parameter of curve, enzyme linked immunoassay type, reagent and analytical equipment.

Further, described reagent device also comprises several support columns, described support column is positioned at below described reagent device matrix, is separated with position, more than one hole between adjacent supports post, and the effect of support column is physical strength in order to strengthen matrix and balance.

Further, in described reagent device, reacting hole is made up of exit orifice and endoporus, the bottom of exit orifice has bottom outlet, endoporus through bottom outlet and with bottom outlet wringing fit, leave anti-overflow chamber between exit orifice and endoporus, the effect in anti-overflow chamber is in course of reaction, if overflow, can stay in chamber, preventing pollution instrument and other reagent devices.

Further, in described reagent device, the myeloperoxidase antigen of the endoporus bag quilt of reacting hole comprises the myeloperoxidase of restructuring or native purified myeloperoxidase.

It is clearly understood that, in the present patent application, in described reagent device, the size of position, each hole, shape are not limited, such as the open peristoma of position, each hole can be square or circular, the shape of its section also can be square, " U " type or " V " type, but for reacting hole, in order to obtain good light penetrability, bottom should be flat.

Further, the sample added in described sample aperture is test serum or blood plasma, and the amount added is determined according to the multiple of the size of sample aperture and the dilution of detection needs.

Described assistant agent hole is the use adding auxiliary reagent when being necessary, such as adsorbent, neutralizing agent, inhibitor, damping fluid etc., to remove the interference to detection reaction and result of other materials in testing process.

Enzyme conjugates solution is added in described enzyme conjugates hole, Main Ingredients and Appearance is anti-human igg or IgA or IgM or Ig (GAM) antibody of horseradish peroxidase-labeled, the anti-human igg of alkali phosphatase enzyme mark or IgA or IgM or Ig (GAM) antibody, the anti-human igg of glucose oxidase thing enzyme labeling or IgA or IgM or Ig (GAM) antibody, or beta galactosidase mark anti-human igg or IgA or IgM or Ig (GAM) antibody.

The substrate solution Main Ingredients and Appearance added in described substrate hole is TMB, OPD or ABTS.

TMB is as a kind of chromogen reagent of new type of safe, progressively replace the benzidine derivative of strong carcinogen biphenylamine and other carcinogenicity, be applied to the fields such as clinical assay, forensic medical examination, criminal detection and environmental monitoring, especially in biochemistry test, TMB, as the new substrate of peroxidase, obtains a wide range of applications in enzyme immunoassay (EIA) (EIA) and enzyme linked immunosorbent assay method (ELISA).

Sulfuric acid or the hydrochloric acid solution of the stop buffer Main Ingredients and Appearance added in described termination fluid apertures to be concentration be 0.1 ~ 0.5M.

The dilution Main Ingredients and Appearance added in described dilution fluid apertures is phosphate buffer, Tris damping fluid, borate buffer solution or carbonate buffer solution, and containing components such as certain density bovine serum albumin(BSA), sodium azide, for getting rid of the interference of the nonspecific reaction of sample small molecular material and increasing stability.

Another object of the present patent application is to provide the detection method utilizing mentioned reagent device to carry out antimyeloperoxidase antibody, and described method comprises following step:

1) in described sample aperture, undiluted sample is added;

2) from dilution fluid apertures, drawing dilution adds in dilution holes;

3) remove the remaining liq in dilution fluid apertures, from dilution holes, draw partially liq return dilution fluid apertures;

4) from sample aperture, draw sample add in dilution fluid apertures, sample is diluted;

5) from dilution fluid apertures, imbitition adds in dilution holes, is further diluted by sample;

6) from dilution holes, imbitition adds in reacting hole, under the condition of 25 ~ 37 DEG C, hatches 30 ~ 60min;

7) liquid is removed after 3 ~ 5 washings being carried out to reacting hole with cleansing solution;

8) from enzyme conjugates hole, drawing enzyme conjugates solution adds in reacting hole, under the condition of 25 ~ 37 DEG C, removes liquid after reaction 30 ~ 60min;

9) step 7 is repeated);

10) from substrate hole, drawing substrate solution adds in reacting hole, under the condition of 25 ~ 37 DEG C, and reaction 10 ~ 20min;

11) from termination fluid apertures, draw stop buffer filling in reacting hole, read OD value in 450nm in 1 ~ 10min, or Double wavelength method measures, wavelength coverage is at 620nm ~ 690nm.

Further, described method comprises following step:

1) in described sample aperture, add undiluted sample, volume is at least 1/4 of sample aperture capacity;

2) from dilution fluid apertures, drawing dilution adds in dilution holes, and the amount of absorption is more than 7/10 of total amount of liquid in hole;

3) remove the remaining liq in dilution fluid apertures, from dilution holes, draw partially liq according to expection extension rate and return dilution fluid apertures;

4) from sample aperture, draw sample add in dilution fluid apertures, diluted by sample, extension rate is 1 ~ 10 times;

5) from dilution fluid apertures, imbitition adds in dilution holes, and further diluted by sample, extension rate is 1 ~ 100 times;

9) step 7 is repeated);

11) from termination fluid apertures, drawing stop buffer adds in reacting hole, reads OD value in 1 ~ 10min in 450nm, or Double wavelength method measures, and wavelength coverage is at 620nm ~ 690nm.

Further, described method comprises following step:

1) in described sample aperture, add sample 80 ~ 150 μ L;

2) from dilution fluid apertures, 360 μ L liquid are drawn in dilution holes with accurate charger;

3) remove the remaining liq in dilution fluid apertures, from dilution holes, draw 180 μ L liquid return dilution fluid apertures;

4) from sample aperture, 20 μ L liquid are drawn in dilution fluid apertures, the dilution of 10 times, sample with accurate charger;

5) with accurate charger from dilution fluid apertures imbitition 20 μ L in dilution holes, the dilution of 100 times, sample;

6) in reacting hole, at 25 ~ 37 DEG C, after hatching 60min, liquid is removed with accurate charger imbitition 100 μ L from dilution fluid apertures;

8) react to reacting hole with the abzyme bond solution that 100 μ L horseradish peroxidase-labeled drawn by accurate charger from enzyme conjugates hole, at 25 ~ 37 DEG C, after reaction 30min, remove liquid;

9) step 7 is repeated);

10) to reacting hole, 10 ~ 15min is reacted with the tmb substrate solution that 100 μ L drawn by accurate charger from substrate hole;

11) annotate in reacting hole from the stop buffer stopping drawing fluid apertures 100 μ L with accurate charger, detects under 450nm and 630nm dual wavelength condition in 1 ~ 10min, read OD value.

Described cleansing solution comprises PBST solution, PBST solution refers to that PBS solution adds Tween-20, PBS solution refers to phosphate buffer (Phosphate Buffer Solution), osmotic pressure is similar to physiological condition, has again very strong pH surge capability, is commonly used to wash cell and the basal liquid as cell chulture, and Tween-20 is a kind of non-ionic surfactant, cell growth can have an impact, and Tween-20 has the effect of renaturation antigen, can improve specific recognition capability.

Reagent device and the method thereof of antimyeloperoxidase antibody is measured described in the present patent application, not only there is high specificity that other detection methods have, highly sensitive, accuracy is good, cost is lower, request for utilization is not high, operation is comparatively easy, obtain the advantage that the testing result time is short, be widely used etc., and solve many deficiencies of other detection methods, be embodied in the following aspects:

1. the detection method described in uses enzyme-linked immuno assay principle, utilize specific analytical instrument, adopt supporting special detection kit and analytical reagent device, automatically realizing antimyeloperoxidase antibody quantitative measurement, is a kind of completely newly, be suitable for, scheme that is practical, that detect antimyeloperoxidase antibody efficiently, fast;

2. it be a kind of independently, the detection reagent of single part and analytical equipment, without the need to using 12 × 8 types, 6 × 8 types, 8 × 12 types or complete plate 96 hole special enzyme-linked immune microwell plate as antigen coated articles for use and reaction vessel as general ELISA method, as long as have a sample can carry out the detection of respective items object in use and without the waste of reagent, if the quantity of sample exceedes portion, use this reagent and analytical equipment by actual sample number;

3. each is detected required reagent and is contained in the reagent wells position of an analytical reagent device by it, and detection reagent need not be carried out splendid attire with different reagent bottles respectively, not only operate very easy, and be not easy to cause bust, thus ensure the correctness of testing result;

4. it has a Special bar code to each analytical reagent device, the numerical value of bar code comprises test item code corresponding to detection, detects reagent product batch number, the reagent term of validity, quantitative measurement typical curve parameter, concrete enzyme linked immunoassay type, reagent and analytical equipment the information such as sequence number, can not arbitrarily be changed, strictly controlled during use, especially when use exceedes term of validity detection reagent, to be identified and stop and send examining report, thus the accuracy of detection can be guaranteed;

5. each detection reagent is effectively separated and seals by it, can not cause the cross pollution between various reagent and affect testing result;

6. it is a kind of analytical reagent device being exclusively used in particular analysis instrument, and annotate with full automatic accurate charger in testing process and detect reagent, cleansing solution or sample, operation automation, dosage is accurate, and accuracy and the precision of testing result are high;

7., in the quantity configuration and use of test item reagent set, all use needs to carry out being equipped with by reality, especially detecting entry, are equipped with more appropriate, there will not be super configuration and service condition.

Accompanying drawing explanation

Fig. 1 is the cross-sectional view of an embodiment of reagent device described in the present patent application;

Fig. 2 is the top plan view of embodiment described in Fig. 1;

Fig. 3 is the cross-sectional view of another embodiment of reagent device described in the present patent application;

Fig. 4 is the top plan view of reacting hole in another embodiment of reagent device described in the present patent application;

Fig. 5 and Fig. 6 is the assembling schematic diagram of endoporus and exit orifice in reacting hole in reagent device described in Fig. 4;

Wherein, 10 be matrix, 20 be handle, 30 be bar code, 40 be sealing film, 50 be support column, 11 be sample aperture, 12 be assistant agent hole, 13 be enzyme conjugates hole, 14 be substrate hole, 15 for stop fluid apertures, 16 for dilution fluid apertures, 17 be reacting hole, 18 be dilution holes, 171 be exit orifice, 172 be endoporus, 173 be anti-overflow chamber, 174 for bottom outlet.

Embodiment

Below in conjunction with concrete pick-up unit and implementation step, the reagent device described in the present patent application and detection method are conducted further description, object is in order to the public better understands technical scheme described in the present patent application instead of the restriction to described technical scheme.In fact, with identical or approximate principle, to the improvement that described reagent device carries out, comprise the change of its shape, size, material used, and the increase and decrease of corresponding construction or replacement, all within the present patent application technical scheme required for protection.

Embodiment one detects the reagent device one of antimyeloperoxidase antibody

As shown in Figure 1-2, the reagent device of the detection antimyeloperoxidase antibody described in the present patent application is strip, comprise the matrix 10 with position, eight holes and the handle 20 being positioned at matrix 10 one end, putting in order of position, eight holes is followed successively by sample aperture 11 from nearly handle 10 end, assistant agent hole 12, enzyme conjugates hole 13, substrate hole 14, stop fluid apertures 15, dilution fluid apertures 16, reacting hole 17 and dilution holes 18, sample to be tested is filled in described sample aperture 11, assistant agent hole 12 adds auxiliary reagent when needing for detection, any reagent is not added in assistant agent hole 12 in the detection method described in the present patent application, enzyme conjugates solution is added in enzyme conjugates hole 13, substrate solution is added in substrate hole 14, stop fluid apertures 15 and add stop buffer, dilution is added in dilution fluid apertures 16, reacting hole 17 is flat and has very high light penetrability, when splendid attire is colourless or Reagent blank solutions time, to the absorbance of visible ray or ultraviolet light or fluorescence close to zero, highly purified myeloperoxidase antigen has been coated with in hole, and to annotate liquid sample to be measured and detect reagent and cleansing solution as reaction vessel, absorbance measurement is carried out after reaction terminating, dilution holes 18 is as Sample Dilution container, during for diluted sample.

Further, in described reagent device, assistant agent hole 12, enzyme conjugates hole 13, substrate hole 14, termination fluid apertures 15 and dilution fluid apertures 16 are coated with sealing film 40, sealing film 40 mainly play transport and movement process in, prevent the effect of overflow, in addition, the effect that preventing dust pollutes and increases stability is also played.

Further, described handle 20 is pasted with bar code 30, this bar code 30 mark has antimyeloperoxidase antibody to detect the information of reagent and analytical equipment, and described information comprises test item code, detects the sequence number of reagent product batch number, the reagent term of validity, quantitative measurement standard parameter of curve, enzyme linked immunoassay type, reagent and analytical equipment.

Embodiment two detects the reagent device two of antimyeloperoxidase antibody

As shown in Figure 3, the reagent device of the detection antimyeloperoxidase antibody in the present embodiment, its basic structure is identical with the reagent device in embodiment one, several support columns 50 are also comprised at described reagent device, described support column 50 is arranged in below described reagent device matrix 10, be separated with position, more than one hole between adjacent supports post 50, the effect of support column 50 is physical strength in order to strengthen matrix and balance.

Embodiment three detects the reagent device three of antimyeloperoxidase antibody

As Figure 4-Figure 6, for detecting the preferred embodiment of the reagent device of antimyeloperoxidase antibody described in the present patent application, its basic structure is identical with embodiment one or embodiment two, difference is that reacting hole 17 is detachable structure, reacting hole 17 is made up of exit orifice 171 and endoporus 172, the bottom of exit orifice 171 has bottom outlet 174, endoporus 172 through bottom outlet 174 and with bottom outlet 174 wringing fit, anti-overflow chamber 173 is left between exit orifice 171 and endoporus 172, the effect in anti-overflow chamber 173 is in course of reaction, if overflow, can stay in chamber, preventing pollution instrument and other reagent devices.

Further, the cooperation fixed form of described endoporus and exit orifice can also be that the outer wall of endoporus is designed to two sections, the thickness of epimere outer wall is greater than the thickness of hypomere outer wall, the diameter of the bottom outlet of exit orifice is equal with the external diameter of endoporus hypomere, like this endoporus hypomere is inserted in bottom outlet, the epimere of endoporus is stuck on bottom outlet just, can play fastening effect equally.

Making-the indirect method of embodiment four reagent device or kit detects antimyeloperoxidase antibody

The present invention is simpler based on the technical one of enzyme linked immunosorbent detection, accurately, effective methodology, its ultimate principle adopted is Dot-ELISA: by the Antigen adsorption that is made up of highly purified myeloperoxidase in solid phase, by hatch make dilution human serum or blood plasma in specific antibody be combined with antigen, the antibody be not combined with solid phase is removed in washing, add the human immunoglobulins's enzyme connection thing by horseradish peroxidase-labeled, hatch, remove unconjugated enzyme connection thing, add enzyme chromogen substrate, the color produced is directly proportional to the specific antibody concentrations detected in sample.This method is mainly by realizing the immune detection of antimyeloperoxidase antibody for the analytical reagent device of enzyme linked immunosorbent detection and matched reagent.By this enzyme-linked immunoassay method, use analytical reagent device and the reagent of particular analysis instrument simultaneously, can be quick, judge accurately and diagnose for adjuvant clinical.

Using position, hole 11 as sample aperture, add liquid sample in use, take for during detection;

Using position, hole 12 as assistant agent hole, with sealing film sealing, for subsequent use for detection;

Using position, hole 13 as enzyme conjugates hole, add enzyme conjugates solution sealing film and seal, take for during detection;

Using position, hole 14 as substrate hole, seal with sealing film after adding tmb substrate solution, during for detection;

Using position, hole 15 as termination fluid apertures, seal with sealing film after adding stop buffer, during for detection;

Using position, hole 16 as dilution fluid apertures, seal with sealing film after adding Sample dilution, during for detection;

Hole/reacting hole/colorimetric hole using position, hole 17 as encrusting substance, has been coated with the antigen of highly purified myeloperoxidase composition, and to annotate liquid sample to be measured and detect reagent and cleansing solution as reaction vessel, carries out absorbance measurement after reaction terminating;

Using position, hole 18 as dilution holes, during for diluted sample;

Be pasted with at handle 20 bar code 30 that antimyeloperoxidase antibody detects reagent and analytical equipment information, this bar code comprises test item code, detects the sequence number of reagent product batch number, the reagent term of validity, quantitative measurement typical curve parameter, enzyme linked immunoassay type, reagent and analytical equipment.

Prepare some analytical equipments according to the method described above, prepare corresponding calibration object and Quality Control thing in addition.So namely, constitute complete antimyeloperoxidase antibody and measure kit component.By detecting the reagent device of antimyeloperoxidase antibody and supporting the use the external packing box of component loading kit, namely make and detect antimyeloperoxidase antibody kit.

The detection method of embodiment five antimyeloperoxidase antibody IgG

The present patent application provides a kind of method utilizing mentioned reagent device to carry out antimyeloperoxidase antibody IgG detection, and described method comprises following step:

1. in described sample aperture, add sample 80 ~ 150 μ L;

2. from dilution fluid apertures, draw 360 μ L liquid in dilution holes with accurate charger;

3. remove the remaining liq in dilution fluid apertures, from dilution holes, draw 180 μ L liquid return dilution fluid apertures;

4. from sample aperture, draw 20 μ L liquid in dilution fluid apertures, the dilution of 10 times, sample with accurate charger;

5. with accurate charger from dilution fluid apertures imbitition 20 μ L in dilution holes, the dilution of 100 times, sample;

6. in reacting hole, at 25 DEG C, after hatching 60min, remove liquid with accurate charger imbitition 100 μ L from dilution fluid apertures;

7. after 3 ~ 5 washings being carried out to reacting hole with cleansing solution, remove liquid;

8. react to reacting hole with anti-human IgG antibodies's enzyme conjugates solution that 100 μ L horseradish peroxidase-labeled drawn by accurate charger from enzyme conjugates hole, at 25 DEG C, after reaction 30min, remove liquid;

9. repeat step 7;

10. to reacting hole, react 10 ~ 15min with the tmb substrate solution that 100 μ L drawn by accurate charger from substrate hole;

11. annotate in reacting hole from the stop buffer stopping drawing fluid apertures 100 μ L with accurate charger, detects, read OD value in 1 ~ 10min under 450nm and 630nm dual wavelength condition.

Embodiment six realizes the analysis operation flow process detected antimyeloperoxidase antibody IgG in sample by fully-automatic analyzer

Further, detection method described in the present patent application also comprise corresponding with the use of fully-automatic analyzer, this fully-automatic analyzer comprises an analytical equipment pallet, it overlaps with the matching form of analytical equipment, one has 30 positions can place for analytical equipment, for detecting analysis, comprising modular integrated mechano-electronic structural level software control system in addition, the filling of robotization can be realized, dilute, hatch, wash, reading, analytic process.Each position independent quantitative is analyzed, and ensures the accuracy of result.After instrument runs, analytical equipment pallet can turn to different positions voluntarily and annotate, and dilution, hatches, the step of washing and reading.

Concrete operation comprises following step:

(1) preparation of scrutiny program: configure corresponding solution on request, comprise lavation buffer solution, cleaning fluid or thimerosal, prepare in the corresponding liquid bottles of complete loading;

(2) be connected with external computing machine: instrument is connected with external computing machine, thus the acquired results that normally worked by instrument transfers to integrated system process;

(3) start shooting: after opening instrument switch, by the working interface of external computing machine to the self-inspection of instrument designing automatic or manual, thus prepare for the normal operation of instrument;

(4) preheating: after powering, instrument can start heating schedule, and temperature is adjusted to temperature to be checked;

(5) inspection is rinsed;

(6) detection of antimyeloperoxidase antibody IgG:

1) from have seal while open the package, take the analytical reagent device of requirement, after deaeration, sack be tamping;

2) solution in Inspection and analysis reagent device tmb substrate hole, should be without color change, otherwise should discard;

3) in the sample aperture of each analytical reagent device, add the undiluted sample of 50 ~ 120 μ L respectively, suggestion adds the sample of 100 μ L, often changes the reagent of a lot number, should get one of them analytical reagent device and calibration object carries out instrument calibration;

4) in analytical equipment pallet, the analytical reagent device of corresponding quantity is put into according to the quantity of required detection, click " beginning ", " scanning ", instrument can automatically scanning analysis reagent device bar code, Quality Control thing bar code and calibration object bar code, then sample is numbered, or by outer strip code scanner, sample bar code is scanned;

5) click " RUN ", instrument runs automatically according to bar code information, and according to bar code, program is testing calibration product first, by calibration, revises typical curve; Secondly Quality Control thing is detected, if its testing result is in the scope indicated, then represents that the typical curve of detection meets the requirements, can be used for the detection of sample, finally start the trace routine of sample;

6) dilute: acupuncture holes position sealing film automatic sucking dilution 360 μ L is in dilution holes in filling, and the remaining liq removed in dilution fluid apertures, from dilution holes, draw dilution 180 μ L again return dilution fluid apertures, filling pin carries out Sample Dilution from sample aperture automatic sucking sample 20 μ L to dilution fluid apertures, 20 μ L are drawn to dilution holes again from dilution fluid apertures, after action completes, moved to reacting hole hatch 30 ~ 60min by the sample diluted pin of being annotated, usual instrument is set as 60min, removes liquid afterwards;

7) wash: flushing needle is drawn after a certain amount of lavation buffer solution carries out three to five washings to reagent wells and removed liquid from corresponding liquid bottle;

8) acupuncture of annotating is broken anti-human IgG antibodies's enzyme conjugates solution that enzyme conjugates hole sealing film draws 100 μ L horseradish peroxidase-labeled and is reacted to reacting hole, and remove liquid after reaction 30 ~ 60min, usual instrument is set as 30min;

9) step 7 is repeated);

10) acupuncture of annotating is broken tmb substrate hole sealing film and is drawn the tmb substrate solution of 100 μ L to reacting hole reaction 10 ~ 20min, and usual instrument is set as 10min;

11) acupuncture of annotating is broken termination fluid apertures sealing film and is drawn the stop buffer filling of 100 μ L to reacting hole, in 1 ~ 10min, read OD value under 450nm/630nm dual wavelength.

(7) testing result: when trace routine is run complete, by the data processing software analysis on computing machine, finally generates report to consult;

(8) shut down: detect after terminating, before instrument shutdown, must clean cycle be started, can avoid from the residual salt crystallization in fluid path in solution like this, avoid damaging instrument or causing testing result invalid, after having cleaned, instrument power source is closed automatically.

The Quality Control of the detection application of antimyeloperoxidase antibody IgG in embodiment seven clinical samples, interpretation of result and detection

Adopt method of operating and the program of embodiment five, use the kit described in embodiment four, can be used for the antimyeloperoxidase antibody IgG level in quantitative measurement human serum or blood plasma.

Myeloperoxidase derives from neutrophil granular, and antimyeloperoxidase antibody IgG is the important symbol thing of autoimmune vasculitis antidiastole.Antimyeloperoxidase antibody is relevant to idiopathic or gangrenosum acne meniscus glomerulonephritis, it be present in the microscopic polyangitis of 70% patient and 5 ~ 50% Churg-Strauss syndrome patient in.Adjuvant clinical diagnosis can be carried out according to the result detected, tentatively judge the situation of patient, finally make a definite diagnosis and should consider in conjunction with clinical manifestation or other diagnostic method/indexs.

Be below the analysis of testing result:

(1) reference value (term of reference)

Normal reference value: 0 ~ 15AU/mL; Detect the negative sample of some (having statistical significance), (namely the mean value of result add 3 times of standard deviations ) be the upper limit of reference value.

(2) explanation of testing result

If sample value > is 15AU/mL, prompting antibody horizontal raises, but should make a definite diagnosis in conjunction with clinical manifestation or other diagnostic method/indexs.

Conveniently clinical practice, we recommend:

Sample value < 12AU/mL is negative

12AU/mL≤sample value≤18AU/mL is suspicious

Sample value > 18AU/mL is positive

When testing result is suspicious, should again detect, if be still suspicious, need after 2 ~ 3 weeks Resurvey pattern detection.

Be below that the testing process duplicate detection of embodiment six is positive and negative quality controlled serum, the repeatability of check result, obtains following result:

According to the present invention, automatically carry out the detection of many increments antimyeloperoxidase antibody originally by identical analytic process simultaneously, and can be associated with other or unconnected project detects simultaneously, this just makes, and detection more simplifies, cost reduces, detection time shortens, cross pollution not easily occurs, detect processing ease carries out; And detect high specificity, highly sensitive, accuracy good.

Claims

1. detect a method for antimyeloperoxidase antibody, it is characterized in that, described method utilizes reagent device and has the fully-automatic analyzer overlapped with reagent device matching form carries out antimyeloperoxidase antibody detection, described reagent device is strip, comprise the matrix with position, eight holes and the handle being positioned at matrix one end, putting in order of position, eight holes is followed successively by sample aperture near handle end, assistant agent hole, enzyme conjugates hole, substrate hole, stop fluid apertures, dilution fluid apertures, reacting hole and dilution holes, sample to be tested is filled in sample aperture, assistant agent hole adds auxiliary reagent whenever necessary for detection, enzyme conjugates solution is filled in enzyme conjugates hole, substrate fills substrate solution in hole, stop filling stop buffer in fluid apertures, dilution is filled in dilution fluid apertures, reacting hole is flat and has high light penetrability, hole endoperidium has myeloperoxidase antigen, and to annotate liquid sample to be measured and detect reagent and cleansing solution as reaction vessel, absorbance measurement is carried out after reaction terminating, dilution holes is as Sample Dilution container, during for diluted sample,

In described reagent device, assistant agent hole, enzyme conjugates hole, substrate hole, termination fluid apertures and dilution fluid apertures are coated with sealing film; Described reagent device also comprises several support columns, and described support column is arranged in below described reagent device matrix, is separated with position, more than one hole between adjacent supports post; In described reagent device, reacting hole is made up of exit orifice and endoporus, the bottom of exit orifice has bottom outlet, endoporus through bottom outlet and with bottom outlet wringing fit, the outer wall of endoporus is designed to two sections, the thickness of epimere outer wall is greater than the thickness of hypomere outer wall, and the bottom diameter of exit orifice is equal with endoporus hypomere external diameter, is inserted by endoporus hypomere in bottom outlet, the epimere of endoporus is stuck on bottom outlet just, leaves anti-overflow chamber between exit orifice and endoporus; In described reagent device, the myeloperoxidase antigen of the endoporus bag quilt of reacting hole comprises the myeloperoxidase of restructuring or native purified myeloperoxidase; After described fully-automatic analyzer runs, reagent device pallet can turn to different positions voluntarily and annotate, and dilution, hatches, the step of washing and reading;

Described method comprises following step:

1) in described sample aperture, undiluted sample is added;

2) from dilution fluid apertures, drawing dilution adds in dilution holes;

9) step 7 is repeated);

11) from termination fluid apertures, drawing stop buffer adds in reacting hole, OD value is read in 450nm in 1 ~ 10min, or Double wavelength method measures, detect under the condition of another wavelength of 620nm ~ 690nm in 450nm and wavelength coverage in 1 ~ 10min, read OD value.

2. method according to claim 1, is characterized in that, described method comprises following step:

1) from dilution fluid apertures, imbitition adds in dilution holes, and further diluted by sample, extension rate is 1 ~ 100 times;

2) from dilution holes, imbitition adds in reacting hole, under the condition of 25 ~ 37 DEG C, hatches 30 ~ 60min;

3) liquid is removed after 3 ~ 5 washings being carried out to reacting hole with cleansing solution;

4) from enzyme conjugates hole, drawing enzyme conjugates solution adds in reacting hole, under the condition of 25 ~ 37 DEG C, removes liquid after reaction 30 ~ 60min;

5) step 7 is repeated);

6) from substrate hole, drawing substrate solution adds in reacting hole, under the condition of 25 ~ 37 DEG C, and reaction 10 ~ 20min;

7) from termination fluid apertures, drawing stop buffer adds in reacting hole, OD value is read in 450nm in 1 ~ 10min, or Double wavelength method measures, detect under the condition of another wavelength of 620nm ~ 690nm in 450nm and wavelength coverage in 1 ~ 10min, read OD value.

3. method according to claim 1, is characterized in that, described method comprises following step:

1) in described sample aperture, add sample 80 ~ 150 μ L;

9) step 7 is repeated);